Healthcare provider profile · identity verified

Jeffrey S Garrett, MD

Cardiology · PITTSBURGH, PA · NPI 1861456527

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	650	183
Losartan Potassium	Losartan Potassium	324	104
Amlodipine Besylate	Amlodipine Besylate	302	97
Metoprolol Succinate	Metoprolol Succinate	271	80
Eliquis	Apixaban	236	51
Metoprolol Tartrate	Metoprolol Tartrate	229	59
Rosuvastatin Calcium	Rosuvastatin Calcium	225	70
Lisinopril	Lisinopril	173	52
Valsartan	Valsartan	165	61
Clopidogrel	Clopidogrel Bisulfate	152	49
Furosemide	Furosemide	148	48
Xarelto	Rivaroxaban	147	34
Omeprazole	Omeprazole	143	46
Hydrochlorothiazide	Hydrochlorothiazide	140	36
Carvedilol	Carvedilol	122	33
Entresto	Sacubitril/Valsartan	109	26
Levothyroxine Sodium	Levothyroxine Sodium	108	25
Repatha Sureclick	Evolocumab	99	22
Simvastatin	Simvastatin	99	27
Atenolol	Atenolol	86	25
Potassium Chloride	Potassium Chloride	83	28
Hydralazine Hcl	Hydralazine Hcl	80	19
Ezetimibe	Ezetimibe	79	20
Warfarin Sodium	Warfarin Sodium	74	suppressed
Famotidine	Famotidine	70	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	70	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	68	21
Tamsulosin Hcl	Tamsulosin Hcl	67	17
Doxazosin Mesylate	Doxazosin Mesylate	66	19
Pantoprazole Sodium	Pantoprazole Sodium	64	22
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	64	18
Nitroglycerin	Nitroglycerin	61	28
Allopurinol	Allopurinol	58	18
Metformin Hcl	Metformin Hcl	56	17
Spironolactone	Spironolactone	55	18
Nifedipine Er	Nifedipine	54	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	48	14
Gabapentin	Gabapentin	47	14
Jardiance	Empagliflozin	40	12
Ranolazine Er	Ranolazine	38	12
Labetalol Hcl	Labetalol Hcl	37	suppressed
Sotalol	Sotalol Hcl	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	12
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Sertraline Hcl	Sertraline Hcl	31	12
Meloxicam	Meloxicam	30	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Multaq	Dronedarone Hcl	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Digoxin	Digoxin	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Brilinta	Ticagrelor	20	suppressed
Flecainide Acetate	Flecainide Acetate	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Clonidine	Clonidine	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Finasteride	Finasteride	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Azithromycin	Azithromycin	13	12
Myrbetriq	Mirabegron	13	suppressed
Repatha Pushtronex	Evolocumab	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Repatha Syringe	Evolocumab	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error